Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules
Sponsors
BioSurface Engineering Technologies, Inc
Conditions
Degenerative Disc DiseaseSpondylolisthesis
Phase 1
Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
NCT00798239
Start: 2008-11-30End: 2012-07-31Target: 24Updated: 2012-03-09
Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
NCT00798902
Start: 2008-11-30End: 2012-10-31Target: 22Updated: 2012-03-09